Explore All 633 Divestiture Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | October 1, 2010 |
| Target | Abbott Laboratories S.A. |
| Sector | Medical Products |
| Buyer(s) | Recipharm |
| Sellers(s) | Abbott |
| Deal Type | Divestiture |
FILTER BY
Recipharm is a global Pharma CDMO providing a full-service offering to leading Pharmaceutical companies and Biotechs globally. Recipharm was founded in 1995 and is based in Stockholm, Sweden.
| Deal Context for Buyer | # |
|---|---|
| Overall | 6 of 18 |
| Sector: Medical Products | 1 of 6 |
| Type: Divestiture | 4 of 8 |
| Country: Spain | 1 of 1 |
| Year: 2010 | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-27 |
Wasserburger Arzneimittelwerk
Wasserburg, Germany Wasserburger Arzneimittelwerk GmbH is a well established contract manufacturing organisation specialised in the aseptic filling and lyophilsation of pharmaceuticals into ampoules and vials on behalf of a wide variety of customers. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-01 |
Corvette Pharmaceutical Services Group
Milan, Italy Corvette Pharmaceutical Services Group SpA is a manufacturer of sterile injectable, API and finished dose form, and lyophilisation of sterile beta lactam antibiotics. |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1888 |
| Sector | Medical Products |
| Employees | 114,000 |
| Revenue | 42.0B USD (2024) |
Abbott is a diversified, global provider of diagnostics, medical devices, nutrition, and pharmaceuticals. Abbott was founded in 1888 and is headquartered in North Chicago, Illinois.
| Deal Context for Seller | # |
|---|---|
| Overall | 3 of 8 |
| Sector: Medical Products | 2 of 5 |
| Type: Divestiture | 2 of 6 |
| Country: Spain | 1 of 1 |
| Year: 2010 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-05-26 |
Piramal Healthcare Generic Drugs
India Piramal Healthcare Generic Drugs is the generic drug unit of Piramal Healthcare. |
Buy | $3.7B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-10-20 |
Visiogen
Irvine, California, United States Visiogen has developed an implantable device to improve vision impairment due to age-related presbyopia. |
Buy | $400M |
